01—Abstract
Summary
Summary of the 8-K filed June 2, 2022. Cited figures are marked; the original filing is the authoritative source.
This 8-K filing from Axon Enterprise, Inc. announces a significant change in its executive leadership.
Effective immediately, Joshua M. Isner has been promoted to Chief Operating Officer. This promotion comes as President Luke S.
Larson begins a medical leave of absence. Mr. Isner, previously the Chief Revenue Officer, will assume Mr. Larson's responsibilities, leveraging his extensive experience in driving global growth and sales operations since joining Axon in 2009. The filing also details the compensation package for James C.
Zito, who is serving as Interim Chief Financial Officer. Mr. Zito will receive a base salary of $550,000a for 2022, with additional cash compensation of $300,000 specifically for his interim CFO role. His equity awards include $650,000 in restricted stock units and $200,000 in performance stock units, with a portion of the PSU value attributed to his interim position.
02—Key points
Key Highlights
- Joshua M. Isner promoted to Chief Operating Officer, effective immediately.
- Isner will assume responsibilities of President Luke S. Larson, who is on medical leave.
- Isner has a long tenure with Axon, previously serving as Chief Revenue Officer since 2018 and holding various roles since 2009.
- President Luke S. Larson is on a medical leave of absence due to a serious health issue.
- James C. Zito's compensation package as Interim Chief Financial Officer is detailed, including a $550,000 salary and significant equity awards.
- Mr. Isner's appointment as COO is not subject to any undisclosed arrangements or reportable transactions under Regulation S-K.
03—Questions
Frequently Asked Questions
What is the immediate impact of Luke S. Larson's medical leave on the company's operations?
Joshua M. Isner, newly promoted to Chief Operating Officer, will assume the responsibilities previously held by President Luke S. Larson. This ensures continuity in leadership and operational oversight during Mr. Larson's medical leave.
What is the compensation for James C. Zito as Interim Chief Financial Officer?
James C. Zito will receive a salary of $550,000 for 2022, which includes $300,000 in additional cash compensation for his role as Interim CFO. He will also receive $100,000 in target incentive compensation, $650,000 in restricted stock units, and $200,000 in performance stock units, with an increased target value for the PSUs due to his interim CFO duties.
What is the expected duration of Luke S. Larson's leave, and will it affect company performance?
The filing states that Mr. Larson is on a medical leave due to a serious health issue. The duration is not specified. While the company expresses full support for Mr. Larson, the CEO's statement highlights Mr. Isner's proven track record in driving revenue growth, suggesting confidence in his ability to manage operations during this period.
Are there any financial implications or new financial reporting requirements due to these executive changes?
This filing primarily relates to executive appointments and compensation. There are no indications of new financial reporting requirements stemming from these changes. The compensation for Mr. Zito as Interim CFO is clearly outlined, and Mr. Isner's appointment as COO has no reportable transactions under Regulation S-K.
04—Continue